Sunshine Biopharma Inc (SBFM)
0.93
+0.04
(+4.49%)
USD |
NASDAQ |
May 17, 16:00
0.92
-0.01
(-1.08%)
After-Hours: 20:00
Sunshine Biopharma Accounts Payable (Quarterly): 2.586M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.586M |
September 30, 2023 | 2.221M |
June 30, 2023 | 1.760M |
March 31, 2023 | 2.736M |
December 31, 2022 | 2.803M |
September 30, 2022 | 0.4802M |
June 30, 2022 | 0.1047M |
March 31, 2022 | 0.0952M |
December 31, 2021 | 0.0429M |
September 30, 2021 | 0.0567M |
June 30, 2021 | 0.1032M |
March 31, 2021 | 0.1486M |
December 31, 2020 | 0.0629M |
September 30, 2020 | 0.0577M |
June 30, 2020 | 0.0899M |
March 31, 2020 | 0.098M |
December 31, 2019 | 0.0969M |
September 30, 2019 | 0.0648M |
June 30, 2019 | 0.0844M |
March 31, 2019 | 0.1403M |
December 31, 2018 | 0.1158M |
September 30, 2018 | 0.105M |
June 30, 2018 | 0.139M |
March 31, 2018 | 0.1134M |
December 31, 2017 | 0.0193M |
Date | Value |
---|---|
September 30, 2017 | 0.0121M |
June 30, 2017 | 0.0347M |
March 31, 2017 | 0.028M |
December 31, 2016 | 0.0281M |
September 30, 2016 | 0.0193M |
June 30, 2016 | 0.0357M |
March 31, 2016 | 0.0245M |
December 31, 2015 | 0.0466M |
September 30, 2015 | 0.0346M |
June 30, 2015 | 0.0357M |
March 31, 2015 | 0.0466M |
December 31, 2014 | 0.0348M |
September 30, 2014 | 0.0513M |
June 30, 2014 | 0.0939M |
March 31, 2014 | 0.0495M |
December 31, 2013 | 0.0238M |
September 30, 2013 | 0.0088M |
June 30, 2013 | 0.0003M |
March 31, 2013 | 0.0083M |
December 31, 2012 | 0.0006M |
September 30, 2012 | 0.0016M |
June 30, 2012 | 0.0165M |
March 31, 2012 | 0.008M |
December 31, 2011 | 0.0034M |
September 30, 2011 | 0.0045M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.0429M
Minimum
Dec 2021
2.803M
Maximum
Dec 2022
0.7206M
Average
0.098M
Median
Mar 2020
Accounts Payable (Quarterly) Benchmarks
Lexaria Bioscience Corp | 0.0477M |
Acasti Pharma Inc | 0.913M |
Aurinia Pharmaceuticals Inc | 4.327M |
Edesa Biotech Inc | -- |
Xenon Pharmaceuticals Inc | 6.43M |